Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study - Test2 - elhamkhani - TriplyDB

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

http://www.wikidata.org/entity/Q24654974

about

Role of insulin in the type 2 diabetes therapy: past, present and future Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Diabetes and gastric cancer: the potential links Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds Diabetes and cancer: two diseases with obesity as a common risk factor The links between insulin resistance, diabetes, and cancer The metabolic and mitogenic properties of basal insulin analogues Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Design of an Insulin Analog with Enhanced Receptor Binding Selectivity: RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONS Supramolecular Protein Engineering: DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT Diabetes and cancer: a consensus report.The effect of environmental chemicals on the tumor microenvironment Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10 Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms.Clinical utility of insulin and insulin analogs.Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.[Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study Nonexperimental comparative effectiveness research using linked healthcare databases Latest insights into the risk of cancer in diabetes Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 Cancer biology in diabetes.Insulin analogs and cancer: a note of caution.Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes.Diabetes medications and cancer risk: review of the literature Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.Diabetes mellitus, fasting glucose, and risk of cause-specific death.Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study.

P2860

Q22241148-DD74FC1A-E2FB-4AB0-B5AD-6E1743898A9D Q24186409-9AFFA0C2-397D-4B1E-80FB-ED8FE1100768 Q24186667-6272654A-8FC4-42D4-ACCD-51B87F19A0F9 Q24194201-86E32AC1-8F39-4E5B-98F8-B659815D3E68 Q24202505-B2BF08CB-750C-4423-BE84-26B8A7101AE1 Q24236456-1079F043-CA2C-4655-87F5-27A49093F378 Q24602836-D9E41806-E52C-4426-827D-B843E0DFD28F Q24630395-C3365400-2936-4A41-A589-3A8E0ADF95EA Q26784381-CD4A6A1C-5955-4BBA-8EFA-0A68866BB07C Q26799120-25EAFB18-0F19-4A3F-B4C5-BD0978EB5EE4 Q26822753-681B354D-E781-4113-9447-BAF9C634597E Q26852910-ED443E12-A672-49C8-AEE4-AB07DD1E8E97 Q26991486-678E0DC0-FEFB-4F5C-8934-2090466C0CC6 Q27024597-BE032955-947D-462E-8E20-E41C018D1588 Q27026813-5ABCC6C1-78D9-458D-890F-8C34C5767FF1 Q27657527-CA8BD354-4601-476A-B499-2319C6CEB3E3 Q27660044-058F7AF3-8210-4A99-B820-B99B1089D71A Q27686977-5736AB8F-1466-4930-B84C-BC887B7731F7 Q28085138-270BB2AD-1FD3-4FED-B929-854AE1372D9B Q28535372-BE84E6DD-B42D-4D54-8ECF-6CCC476945AD Q28547270-F24FCA76-2561-45A3-8E33-35AA522C275A Q28597192-1C292D89-C7D3-4112-9D1E-7BBEED1EDC25 Q28730070-B23F2876-2CEE-464E-A84F-D8A1C1F83132 Q30410721-02802290-450A-471B-9CE9-B5C0C0AD36B8 Q30429358-B25CD620-2C2B-4656-8A4A-B400A56E6379 Q30652699-E5130442-1B40-4A0E-952D-5C7C5F76C4FB Q30662831-4746B371-6A65-40D7-A530-45C549573D61 Q30719834-18FCDBE9-9C26-4DA5-A1E8-FA5C0DC0FEE2 Q33508691-A72EDE90-A07D-4FA1-8FB7-CFDCCE45511B Q33576469-168A081A-87E8-49A9-8808-570D858615B6 Q33588852-4D123899-FA0C-4FF6-98B9-045D730ABB40 Q33602223-EC1F54FD-A122-4248-A70C-250AD9B01EC5 Q33608038-DAD4E83F-1FAF-42EF-9065-8D3DED5B2CA2 Q33660524-0B065D46-1E64-4AD8-AAA2-D1513D247FF3 Q33695887-F3275589-6DAF-4829-898E-1615270B445B Q33714881-A6E1E267-3BBC-43E9-91E8-509E6446B099 Q33773202-DB9C7E71-0352-4FE7-A31D-8A3DFF5657A3 Q33803499-76577AB9-03CA-4FD4-9725-3055A52F9CD4 Q33945937-0E636329-BECE-4F15-BD0F-11A77FC381ED Q33954827-FA93A8F3-9FBE-47E1-AF91-5CD5DA704D98

P2860

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

http://www.wikidata.org/entity/Q24654974

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Risk of malignancies in patien ...... ulin analogues: a cohort study

@ast

Risk of malignancies in patien ...... ulin analogues: a cohort study

@en

Risk of malignancies in patien ...... ulin analogues: a cohort study

@nl

type

label

Risk of malignancies in patien ...... ulin analogues: a cohort study

@ast

Risk of malignancies in patien ...... ulin analogues: a cohort study

@en

Risk of malignancies in patien ...... ulin analogues: a cohort study

@nl

prefLabel

Risk of malignancies in patien ...... ulin analogues: a cohort study

@ast

Risk of malignancies in patien ...... ulin analogues: a cohort study

@en

Risk of malignancies in patien ...... ulin analogues: a cohort study

@nl

P1433

Q24654974-2EB5CD55-7117-44C1-9209-90014194958A

P1476

Q24654974-269EEC0E-30D7-4015-969A-CB0672074EAA

P2093

Q24654974-478BD414-DB60-4DA1-AA2A-C90B0F946D8F

Q24654974-57696AFB-1E7F-4885-A7C7-470B453A56AA

Q24654974-8244830D-AA4A-4F9A-994B-7D0019CCB755

Q24654974-8337261B-776E-4D65-A692-08A1A42B5E00

Q24654974-9DC341DC-B467-43A2-97B8-194F080701AD

Q24654974-E2BDB88E-608D-412F-979C-5BAAAF142457

P2860

Q24654974-0DED0D95-0AD6-4A4D-8E34-6AD199347B98

Q24654974-137EA1AF-0FFC-4C42-8539-F3A460C0E2FB

Q24654974-1B6C2B09-82FB-460E-BD37-A806D18309A3

Q24654974-32E6E2D0-0DB3-415B-BB9C-AE995AE77F49

Q24654974-39B3F6E2-8F8C-4DBB-9938-50C7E31C1762

Q24654974-3BCF4EDF-9CA3-4CD4-909B-2F47227DE654

Q24654974-55414E2B-5EC6-4D69-B5D8-4356CCD3E183

Q24654974-6A7E6ADA-EDB2-489C-AAE3-E881B1638946

Q24654974-73DE0F23-82E9-4E72-8AAB-4642ED0405D9

Q24654974-7CC540DF-D7BF-4D2B-864F-076971C607A1

P2888

Q24654974-FF3817FF-D625-45BE-9C06-9DC6336D1D5E

P304

Q24654974-0515B029-5647-4BF2-8E02-46DA44AC604F

P31

Q24654974-A894A132-BC7A-41D0-9661-93F37D6785AE

P3181

Q24654974-F85104CD-3D34-4652-8FD4-CD0312162D5F

P356

Q24654974-57335618-0B2B-4238-88DB-1185CF79357F

P407

Q24654974-84E1AE88-CD95-4108-8A54-399C31B3AC33

P433

Q24654974-E4604594-335A-4B5B-BF95-CDA2C88FB216

P478

Q24654974-404F271C-C80D-4231-B55F-40ECBB9605AC

P50

Q24654974-1E801B4E-CAE2-4924-80B3-1815A3EFC637

P577

Q24654974-145939A2-21A3-45DB-B3A5-5054255CCA03

P5875

Q24654974-2344F2B8-6A63-419B-8460-1D617BEED4D2

P6179

Q24654974-0644F86C-20B7-4F0E-984A-C9A83E41D5A1

P698

Q24654974-DA748809-D62F-420B-86E9-55B2A1B41153

P921

Q24654974-64A95DBC-C004-424B-BFD4-023C6980E20D

Q24654974-93687780-3EDE-4DB6-A491-3A5076842CCB

P932

Q24654974-D9F9C1BC-D8D9-4EBC-856F-49483279CCB8

P3181

P356

S00125-009-1418-4

P1433

P1476

Risk of malignancies in patien ...... ulin analogues: a cohort study

@en

P2093

C Günster

http://www.w3.org/2001/XMLSchema#string

G W Selke

http://www.w3.org/2001/XMLSchema#string

P T Sawicki

http://www.w3.org/2001/XMLSchema#string

R Bender

http://www.w3.org/2001/XMLSchema#string

S Gutschmidt

http://www.w3.org/2001/XMLSchema#string

U Grouven

http://www.w3.org/2001/XMLSchema#string

P2860

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

Metformin and reduced risk of cancer in diabetic patients

Adjusting for multiple testing--when and how?

Insulins today and beyond.

Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Diabetes mellitus and risk of breast cancer: a meta-analysis.

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.

Reliability of causes of death in persons with Type I diabetes.

P2888

s00125-009-1418-4

P304

1732-1744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1066925

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00125-009-1418-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26329201

http://www.w3.org/2001/XMLSchema#string

P6179

1019944234

http://www.w3.org/2001/XMLSchema#string

P698

19565214

http://www.w3.org/2001/XMLSchema#string

P921

P932

2723679

http://www.w3.org/2001/XMLSchema#string